In this study, we systematically investigated the tumor microenvironment (TME) of breast cancer, including the ER+, HER2+, and TNBC subtypes, by integrating multiple datasets that leverage information from large cohorts of patients and cell samples, along with clinical data. The gene discussed is ERBB2; the disease is breast carcinoma.